newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting

OTTAWA, ON, May 31, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, held its annual general and special meeting (the "Meeting") o